Lamia B, Hellot M-F, Girault C, Tamion F, Dachraoui F, Lenain P, Bonmarchand G
Kremlin-Bicêtre University Hospital, Medical Intensive Care Department, 78 rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France.
Intensive Care Med. 2006 Oct;32(10):1560-8. doi: 10.1007/s00134-006-0286-3. Epub 2006 Aug 1.
To determine whether severity and organ failure scores over the first 3 days in an ICU predict in-hospital mortality in onco-hematological malignancy patients.
Retrospective study in a 22-bed medical ICU.
92 consecutive patients with onco-hematological malignancies including 20 hematopoietic stem cell transplantation (HSCT) patients (11 with allogenic HSCT).
Simplified Acute Physiology Score (SAPS) II, Organ Dysfunction and/or Infection (ODIN) score, Logistic Organ Dysfunction System (LODS), and Sequential Organ Failure Assessment (SOFA) score were recorded on admission. The change in each score (Delta score) during the first 3 days in the ICU was calculated as follows: severity or organ failure score on day 3 minus severity or organ failure score on day 1, divided by severity or organ failure score on day 1.
In-hospital mortality was 58%. Using multivariate analysis in-hospital mortality was predicted by all scores on day 1 and all Delta scores. Areas under the receiver operating characteristics curves were similar for SAPS II (0.78), ODIN (0.78), LODS (0.83), and SOFA (0.78) scores at day 1. They were also similar for DeltaSAPS II, DeltaODIN, DeltaLODS, and DeltaSOFA. Similar results were observed when excluding patients with allogenic HSCT.
Severity and three organ failure scores on day 1 and Delta scores perform similarly in predicting in-hospital mortality in ICU onco-hematological malignancy patients but do not predict individual outcome. Decision to admit such patients to the ICU or to forgo life-sustaining therapies should not be based on these scores.
确定重症监护病房(ICU)中前3天的病情严重程度和器官衰竭评分是否可预测肿瘤血液系统恶性肿瘤患者的院内死亡率。
在一个拥有22张床位的内科ICU进行的回顾性研究。
92例连续性肿瘤血液系统恶性肿瘤患者,包括20例造血干细胞移植(HSCT)患者(11例接受异基因HSCT)。
入院时记录简化急性生理学评分(SAPS)II、器官功能障碍和/或感染(ODIN)评分、逻辑器官功能障碍系统(LODS)和序贯器官衰竭评估(SOFA)评分。ICU中前3天各评分的变化(Delta评分)计算如下:第3天的病情严重程度或器官衰竭评分减去第1天的病情严重程度或器官衰竭评分,再除以第1天的病情严重程度或器官衰竭评分。
院内死亡率为58%。多因素分析显示,第1天的所有评分和所有Delta评分均可预测院内死亡率。第1天SAPS II(0.78)、ODIN(0.78)、LODS(0.83)和SOFA(0.78)评分的受试者工作特征曲线下面积相似。DeltaSAPS II、DeltaODIN、DeltaLODS和DeltaSOFA的曲线下面积也相似。排除异基因HSCT患者后观察到类似结果。
第1天的病情严重程度和三个器官衰竭评分以及Delta评分在预测ICU肿瘤血液系统恶性肿瘤患者的院内死亡率方面表现相似,但不能预测个体预后。将此类患者收入ICU或放弃生命维持治疗的决策不应基于这些评分。